Loading…

dl-propargylglycine reduces blood pressure and renal injury but increases kidney weight in angiotensin-II infused rats

Hydrogen sulfide (H2S), carbon monoxide (CO) and nitric oxide (NO) share signaling and vasorelaxant properties and are involved in proliferation and apoptosis. Inhibiting NO production or availability induces hypertension and proteinuria, which is prevented by concomitant blockade of the H2S produci...

Full description

Saved in:
Bibliographic Details
Published in:Nitric oxide 2015-09, Vol.49, p.56-66
Main Authors: Oosterhuis, Nynke R., Frenay, Anne-Roos S., Wesseling, Sebastiaan, Snijder, Pauline M., Slaats, Gisela G., Yazdani, Saleh, Fernandez, Bernadette O., Feelisch, Martin, Giles, Rachel H., Verhaar, Marianne C., Joles, Jaap A., van Goor, Harry
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c451t-3e7b6a82659b54ff9a9de0852f0e4ea7b961ba93328a6133b9bd142032d9dcdf3
cites cdi_FETCH-LOGICAL-c451t-3e7b6a82659b54ff9a9de0852f0e4ea7b961ba93328a6133b9bd142032d9dcdf3
container_end_page 66
container_issue
container_start_page 56
container_title Nitric oxide
container_volume 49
creator Oosterhuis, Nynke R.
Frenay, Anne-Roos S.
Wesseling, Sebastiaan
Snijder, Pauline M.
Slaats, Gisela G.
Yazdani, Saleh
Fernandez, Bernadette O.
Feelisch, Martin
Giles, Rachel H.
Verhaar, Marianne C.
Joles, Jaap A.
van Goor, Harry
description Hydrogen sulfide (H2S), carbon monoxide (CO) and nitric oxide (NO) share signaling and vasorelaxant properties and are involved in proliferation and apoptosis. Inhibiting NO production or availability induces hypertension and proteinuria, which is prevented by concomitant blockade of the H2S producing enzyme cystathionine γ-lyase (CSE) by d,l-propargylglycine (PAG). We hypothesized that blocking H2S production ameliorates Angiotensin II (AngII)-induced hypertension and renal injury in a rodent model. Effects of concomitant administration of PAG or saline were therefore studied in healthy (CON) and AngII hypertensive rats. In CON rats, PAG did not affect systolic blood pressure (SBP), but slightly increased proteinuria. In AngII rats PAG reduced SBP, proteinuria and plasma creatinine (180 ± 12 vs. 211 ± 19 mmHg; 66 ± 35 vs. 346 ± 92 mg/24 h; 24 ± 6 vs. 47 ± 15 μmol/L, respectively; p 
doi_str_mv 10.1016/j.niox.2015.07.001
format article
fullrecord <record><control><sourceid>elsevier_wagen</sourceid><recordid>TN_cdi_wageningen_narcis_oai_library_wur_nl_wurpubs_501590</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1089860315300021</els_id><sourcerecordid>S1089860315300021</sourcerecordid><originalsourceid>FETCH-LOGICAL-c451t-3e7b6a82659b54ff9a9de0852f0e4ea7b961ba93328a6133b9bd142032d9dcdf3</originalsourceid><addsrcrecordid>eNp9kc9u1DAQxi1UREvhBThUeYGEsZ14Y8SlqgqsVIkLnC3_mQRvUyeyky55exxtu0cuntH4933SzEfIJwoVBSo-H6rgx78VA9pUsKsA6BtyRaGVZSsovTj3wC_J-5QOAFDzVrwjl0xQybjgV-TZDeUUx0nHfh36YbU-YBHRLRZTYYZxdMUUMaUlYqGDy19BD4UPhyWuhVnm3NqIOmX60buAa3FE3__Z5pnv_ThjSD6U-32edEvCbKHn9IG87fSQ8ONLvSa_v93_uvtRPvz8vr-7fSht3dC55LgzQrdMNNI0dddJLR1C27AOsEa9M1JQoyXnrNWCcm6kcbRmwJmTzrqOX5MvJ9-j7jH4kB8VdLQ-qVF7NXgTdVzVcYkqDFuZFpNUky8qIYvZSWzjmFLETk3RP208BbUloA5qS0BtCSjYqZxAFt2cRNnpCd1Z8nryDHw9AZj3fvYYVbIeg0XnI9pZudH_z_8fqKecVw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>dl-propargylglycine reduces blood pressure and renal injury but increases kidney weight in angiotensin-II infused rats</title><source>Elsevier</source><creator>Oosterhuis, Nynke R. ; Frenay, Anne-Roos S. ; Wesseling, Sebastiaan ; Snijder, Pauline M. ; Slaats, Gisela G. ; Yazdani, Saleh ; Fernandez, Bernadette O. ; Feelisch, Martin ; Giles, Rachel H. ; Verhaar, Marianne C. ; Joles, Jaap A. ; van Goor, Harry</creator><creatorcontrib>Oosterhuis, Nynke R. ; Frenay, Anne-Roos S. ; Wesseling, Sebastiaan ; Snijder, Pauline M. ; Slaats, Gisela G. ; Yazdani, Saleh ; Fernandez, Bernadette O. ; Feelisch, Martin ; Giles, Rachel H. ; Verhaar, Marianne C. ; Joles, Jaap A. ; van Goor, Harry</creatorcontrib><description>Hydrogen sulfide (H2S), carbon monoxide (CO) and nitric oxide (NO) share signaling and vasorelaxant properties and are involved in proliferation and apoptosis. Inhibiting NO production or availability induces hypertension and proteinuria, which is prevented by concomitant blockade of the H2S producing enzyme cystathionine γ-lyase (CSE) by d,l-propargylglycine (PAG). We hypothesized that blocking H2S production ameliorates Angiotensin II (AngII)-induced hypertension and renal injury in a rodent model. Effects of concomitant administration of PAG or saline were therefore studied in healthy (CON) and AngII hypertensive rats. In CON rats, PAG did not affect systolic blood pressure (SBP), but slightly increased proteinuria. In AngII rats PAG reduced SBP, proteinuria and plasma creatinine (180 ± 12 vs. 211 ± 19 mmHg; 66 ± 35 vs. 346 ± 92 mg/24 h; 24 ± 6 vs. 47 ± 15 μmol/L, respectively; p &lt; 0.01). Unexpectedly, kidney to body weight ratio was increased in all groups by PAG (p &lt; 0.05). Renal injury induced by AngII was reduced by PAG (p &lt; 0.001). HO-1 gene expression was increased by PAG alone (p &lt; 0.05). PAG increased inner cortical tubular cell proliferation after 1 week and decreased outer cortical tubular nucleus number/field after 4 weeks. In vitro proximal tubular cell size increased after exposure to PAG. In summary, blocking H2S production with PAG reduced SBP and renal injury in AngII infused rats. Independent of the cardiovascular and renal effects, PAG increased HO-1 gene expression and kidney weight. PAG alone increased tubular cell size and proliferation in-vivo and in-vitro. Our results are indicative of a complex interplay of gasotransmitter signaling/action of mutually compensatory nature in the kidney. •dl-propargylglycine (PAG) abolished H2S production in the kidney.•PAG reduced systolic blood pressure and renal injury in angiotensin II-infused rats.•Independent of kidney function PAG increased kidney weight.•PAG increased tubular cell size and proliferation.</description><identifier>ISSN: 1089-8603</identifier><identifier>EISSN: 1089-8611</identifier><identifier>DOI: 10.1016/j.niox.2015.07.001</identifier><identifier>PMID: 26192363</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Acute Kidney Injury - chemically induced ; Acute Kidney Injury - metabolism ; Alkynes - administration &amp; dosage ; Alkynes - pharmacology ; Angiotensin II - adverse effects ; Angiotensin-II ; Animals ; Blood Pressure - drug effects ; Cell Proliferation ; DL-Propargylglycine ; Glycine - administration &amp; dosage ; Glycine - analogs &amp; derivatives ; Glycine - pharmacology ; Heme Oxygenase-1 - metabolism ; Hydrogen sulfide ; Hydrogen Sulfide - metabolism ; Hypertension ; Kidney - drug effects ; Kidney - pathology ; Kidney weight ; Male ; Nitric Oxide ; Organ Size ; Proteinuria ; Rats ; Rats, Sprague-Dawley</subject><ispartof>Nitric oxide, 2015-09, Vol.49, p.56-66</ispartof><rights>2015 Elsevier Inc.</rights><rights>Copyright © 2015 Elsevier Inc. All rights reserved.</rights><rights>Wageningen University &amp; Research</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c451t-3e7b6a82659b54ff9a9de0852f0e4ea7b961ba93328a6133b9bd142032d9dcdf3</citedby><cites>FETCH-LOGICAL-c451t-3e7b6a82659b54ff9a9de0852f0e4ea7b961ba93328a6133b9bd142032d9dcdf3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26192363$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Oosterhuis, Nynke R.</creatorcontrib><creatorcontrib>Frenay, Anne-Roos S.</creatorcontrib><creatorcontrib>Wesseling, Sebastiaan</creatorcontrib><creatorcontrib>Snijder, Pauline M.</creatorcontrib><creatorcontrib>Slaats, Gisela G.</creatorcontrib><creatorcontrib>Yazdani, Saleh</creatorcontrib><creatorcontrib>Fernandez, Bernadette O.</creatorcontrib><creatorcontrib>Feelisch, Martin</creatorcontrib><creatorcontrib>Giles, Rachel H.</creatorcontrib><creatorcontrib>Verhaar, Marianne C.</creatorcontrib><creatorcontrib>Joles, Jaap A.</creatorcontrib><creatorcontrib>van Goor, Harry</creatorcontrib><title>dl-propargylglycine reduces blood pressure and renal injury but increases kidney weight in angiotensin-II infused rats</title><title>Nitric oxide</title><addtitle>Nitric Oxide</addtitle><description>Hydrogen sulfide (H2S), carbon monoxide (CO) and nitric oxide (NO) share signaling and vasorelaxant properties and are involved in proliferation and apoptosis. Inhibiting NO production or availability induces hypertension and proteinuria, which is prevented by concomitant blockade of the H2S producing enzyme cystathionine γ-lyase (CSE) by d,l-propargylglycine (PAG). We hypothesized that blocking H2S production ameliorates Angiotensin II (AngII)-induced hypertension and renal injury in a rodent model. Effects of concomitant administration of PAG or saline were therefore studied in healthy (CON) and AngII hypertensive rats. In CON rats, PAG did not affect systolic blood pressure (SBP), but slightly increased proteinuria. In AngII rats PAG reduced SBP, proteinuria and plasma creatinine (180 ± 12 vs. 211 ± 19 mmHg; 66 ± 35 vs. 346 ± 92 mg/24 h; 24 ± 6 vs. 47 ± 15 μmol/L, respectively; p &lt; 0.01). Unexpectedly, kidney to body weight ratio was increased in all groups by PAG (p &lt; 0.05). Renal injury induced by AngII was reduced by PAG (p &lt; 0.001). HO-1 gene expression was increased by PAG alone (p &lt; 0.05). PAG increased inner cortical tubular cell proliferation after 1 week and decreased outer cortical tubular nucleus number/field after 4 weeks. In vitro proximal tubular cell size increased after exposure to PAG. In summary, blocking H2S production with PAG reduced SBP and renal injury in AngII infused rats. Independent of the cardiovascular and renal effects, PAG increased HO-1 gene expression and kidney weight. PAG alone increased tubular cell size and proliferation in-vivo and in-vitro. Our results are indicative of a complex interplay of gasotransmitter signaling/action of mutually compensatory nature in the kidney. •dl-propargylglycine (PAG) abolished H2S production in the kidney.•PAG reduced systolic blood pressure and renal injury in angiotensin II-infused rats.•Independent of kidney function PAG increased kidney weight.•PAG increased tubular cell size and proliferation.</description><subject>Acute Kidney Injury - chemically induced</subject><subject>Acute Kidney Injury - metabolism</subject><subject>Alkynes - administration &amp; dosage</subject><subject>Alkynes - pharmacology</subject><subject>Angiotensin II - adverse effects</subject><subject>Angiotensin-II</subject><subject>Animals</subject><subject>Blood Pressure - drug effects</subject><subject>Cell Proliferation</subject><subject>DL-Propargylglycine</subject><subject>Glycine - administration &amp; dosage</subject><subject>Glycine - analogs &amp; derivatives</subject><subject>Glycine - pharmacology</subject><subject>Heme Oxygenase-1 - metabolism</subject><subject>Hydrogen sulfide</subject><subject>Hydrogen Sulfide - metabolism</subject><subject>Hypertension</subject><subject>Kidney - drug effects</subject><subject>Kidney - pathology</subject><subject>Kidney weight</subject><subject>Male</subject><subject>Nitric Oxide</subject><subject>Organ Size</subject><subject>Proteinuria</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><issn>1089-8603</issn><issn>1089-8611</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNp9kc9u1DAQxi1UREvhBThUeYGEsZ14Y8SlqgqsVIkLnC3_mQRvUyeyky55exxtu0cuntH4933SzEfIJwoVBSo-H6rgx78VA9pUsKsA6BtyRaGVZSsovTj3wC_J-5QOAFDzVrwjl0xQybjgV-TZDeUUx0nHfh36YbU-YBHRLRZTYYZxdMUUMaUlYqGDy19BD4UPhyWuhVnm3NqIOmX60buAa3FE3__Z5pnv_ThjSD6U-32edEvCbKHn9IG87fSQ8ONLvSa_v93_uvtRPvz8vr-7fSht3dC55LgzQrdMNNI0dddJLR1C27AOsEa9M1JQoyXnrNWCcm6kcbRmwJmTzrqOX5MvJ9-j7jH4kB8VdLQ-qVF7NXgTdVzVcYkqDFuZFpNUky8qIYvZSWzjmFLETk3RP208BbUloA5qS0BtCSjYqZxAFt2cRNnpCd1Z8nryDHw9AZj3fvYYVbIeg0XnI9pZudH_z_8fqKecVw</recordid><startdate>20150915</startdate><enddate>20150915</enddate><creator>Oosterhuis, Nynke R.</creator><creator>Frenay, Anne-Roos S.</creator><creator>Wesseling, Sebastiaan</creator><creator>Snijder, Pauline M.</creator><creator>Slaats, Gisela G.</creator><creator>Yazdani, Saleh</creator><creator>Fernandez, Bernadette O.</creator><creator>Feelisch, Martin</creator><creator>Giles, Rachel H.</creator><creator>Verhaar, Marianne C.</creator><creator>Joles, Jaap A.</creator><creator>van Goor, Harry</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>QVL</scope></search><sort><creationdate>20150915</creationdate><title>dl-propargylglycine reduces blood pressure and renal injury but increases kidney weight in angiotensin-II infused rats</title><author>Oosterhuis, Nynke R. ; Frenay, Anne-Roos S. ; Wesseling, Sebastiaan ; Snijder, Pauline M. ; Slaats, Gisela G. ; Yazdani, Saleh ; Fernandez, Bernadette O. ; Feelisch, Martin ; Giles, Rachel H. ; Verhaar, Marianne C. ; Joles, Jaap A. ; van Goor, Harry</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c451t-3e7b6a82659b54ff9a9de0852f0e4ea7b961ba93328a6133b9bd142032d9dcdf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Acute Kidney Injury - chemically induced</topic><topic>Acute Kidney Injury - metabolism</topic><topic>Alkynes - administration &amp; dosage</topic><topic>Alkynes - pharmacology</topic><topic>Angiotensin II - adverse effects</topic><topic>Angiotensin-II</topic><topic>Animals</topic><topic>Blood Pressure - drug effects</topic><topic>Cell Proliferation</topic><topic>DL-Propargylglycine</topic><topic>Glycine - administration &amp; dosage</topic><topic>Glycine - analogs &amp; derivatives</topic><topic>Glycine - pharmacology</topic><topic>Heme Oxygenase-1 - metabolism</topic><topic>Hydrogen sulfide</topic><topic>Hydrogen Sulfide - metabolism</topic><topic>Hypertension</topic><topic>Kidney - drug effects</topic><topic>Kidney - pathology</topic><topic>Kidney weight</topic><topic>Male</topic><topic>Nitric Oxide</topic><topic>Organ Size</topic><topic>Proteinuria</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Oosterhuis, Nynke R.</creatorcontrib><creatorcontrib>Frenay, Anne-Roos S.</creatorcontrib><creatorcontrib>Wesseling, Sebastiaan</creatorcontrib><creatorcontrib>Snijder, Pauline M.</creatorcontrib><creatorcontrib>Slaats, Gisela G.</creatorcontrib><creatorcontrib>Yazdani, Saleh</creatorcontrib><creatorcontrib>Fernandez, Bernadette O.</creatorcontrib><creatorcontrib>Feelisch, Martin</creatorcontrib><creatorcontrib>Giles, Rachel H.</creatorcontrib><creatorcontrib>Verhaar, Marianne C.</creatorcontrib><creatorcontrib>Joles, Jaap A.</creatorcontrib><creatorcontrib>van Goor, Harry</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>NARCIS:Publications</collection><jtitle>Nitric oxide</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Oosterhuis, Nynke R.</au><au>Frenay, Anne-Roos S.</au><au>Wesseling, Sebastiaan</au><au>Snijder, Pauline M.</au><au>Slaats, Gisela G.</au><au>Yazdani, Saleh</au><au>Fernandez, Bernadette O.</au><au>Feelisch, Martin</au><au>Giles, Rachel H.</au><au>Verhaar, Marianne C.</au><au>Joles, Jaap A.</au><au>van Goor, Harry</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>dl-propargylglycine reduces blood pressure and renal injury but increases kidney weight in angiotensin-II infused rats</atitle><jtitle>Nitric oxide</jtitle><addtitle>Nitric Oxide</addtitle><date>2015-09-15</date><risdate>2015</risdate><volume>49</volume><spage>56</spage><epage>66</epage><pages>56-66</pages><issn>1089-8603</issn><eissn>1089-8611</eissn><abstract>Hydrogen sulfide (H2S), carbon monoxide (CO) and nitric oxide (NO) share signaling and vasorelaxant properties and are involved in proliferation and apoptosis. Inhibiting NO production or availability induces hypertension and proteinuria, which is prevented by concomitant blockade of the H2S producing enzyme cystathionine γ-lyase (CSE) by d,l-propargylglycine (PAG). We hypothesized that blocking H2S production ameliorates Angiotensin II (AngII)-induced hypertension and renal injury in a rodent model. Effects of concomitant administration of PAG or saline were therefore studied in healthy (CON) and AngII hypertensive rats. In CON rats, PAG did not affect systolic blood pressure (SBP), but slightly increased proteinuria. In AngII rats PAG reduced SBP, proteinuria and plasma creatinine (180 ± 12 vs. 211 ± 19 mmHg; 66 ± 35 vs. 346 ± 92 mg/24 h; 24 ± 6 vs. 47 ± 15 μmol/L, respectively; p &lt; 0.01). Unexpectedly, kidney to body weight ratio was increased in all groups by PAG (p &lt; 0.05). Renal injury induced by AngII was reduced by PAG (p &lt; 0.001). HO-1 gene expression was increased by PAG alone (p &lt; 0.05). PAG increased inner cortical tubular cell proliferation after 1 week and decreased outer cortical tubular nucleus number/field after 4 weeks. In vitro proximal tubular cell size increased after exposure to PAG. In summary, blocking H2S production with PAG reduced SBP and renal injury in AngII infused rats. Independent of the cardiovascular and renal effects, PAG increased HO-1 gene expression and kidney weight. PAG alone increased tubular cell size and proliferation in-vivo and in-vitro. Our results are indicative of a complex interplay of gasotransmitter signaling/action of mutually compensatory nature in the kidney. •dl-propargylglycine (PAG) abolished H2S production in the kidney.•PAG reduced systolic blood pressure and renal injury in angiotensin II-infused rats.•Independent of kidney function PAG increased kidney weight.•PAG increased tubular cell size and proliferation.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>26192363</pmid><doi>10.1016/j.niox.2015.07.001</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1089-8603
ispartof Nitric oxide, 2015-09, Vol.49, p.56-66
issn 1089-8603
1089-8611
language eng
recordid cdi_wageningen_narcis_oai_library_wur_nl_wurpubs_501590
source Elsevier
subjects Acute Kidney Injury - chemically induced
Acute Kidney Injury - metabolism
Alkynes - administration & dosage
Alkynes - pharmacology
Angiotensin II - adverse effects
Angiotensin-II
Animals
Blood Pressure - drug effects
Cell Proliferation
DL-Propargylglycine
Glycine - administration & dosage
Glycine - analogs & derivatives
Glycine - pharmacology
Heme Oxygenase-1 - metabolism
Hydrogen sulfide
Hydrogen Sulfide - metabolism
Hypertension
Kidney - drug effects
Kidney - pathology
Kidney weight
Male
Nitric Oxide
Organ Size
Proteinuria
Rats
Rats, Sprague-Dawley
title dl-propargylglycine reduces blood pressure and renal injury but increases kidney weight in angiotensin-II infused rats
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T10%3A58%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_wagen&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=dl-propargylglycine%20reduces%20blood%20pressure%20and%20renal%20injury%20but%20increases%20kidney%20weight%20in%20angiotensin-II%20infused%20rats&rft.jtitle=Nitric%20oxide&rft.au=Oosterhuis,%20Nynke%20R.&rft.date=2015-09-15&rft.volume=49&rft.spage=56&rft.epage=66&rft.pages=56-66&rft.issn=1089-8603&rft.eissn=1089-8611&rft_id=info:doi/10.1016/j.niox.2015.07.001&rft_dat=%3Celsevier_wagen%3ES1089860315300021%3C/elsevier_wagen%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c451t-3e7b6a82659b54ff9a9de0852f0e4ea7b961ba93328a6133b9bd142032d9dcdf3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/26192363&rfr_iscdi=true